Lymphedema after cancer treatment -- special issue of Rehabilitation Oncology presents research update

January 04, 2018

Jan. 4, 2018 - Individuals who have been treated for cancer are at risk for a complication called lymphedema: swelling in the body region where lymph nodes were removed, causing pain and limited function. New research and insights on the management of cancer-related lymphedema are presented in the January special issue of Rehabilitation Oncology, official journal of the Oncology Section of the American Physical Therapy Association. The journal is published by Wolters Kluwer.

The special issue highlights progress in rehabilitation and physical therapy management of cancer-related lymphedema--including a new study identifying characteristics of patients who need extra support in practicing essential self-care. Other articles point toward ongoing advances in lymphedema care, including new imaging techniques, and technologies to help patients monitor and control their condition, according to an introduction by Guest Editor Nicole L. Stout, DPT, CLT-LANA, FAPTA.

New Research Builds on Past Progress in Lymphedema Management Lymphedema is a complication of cancer treatment that occurs due to fluid buildup in soft tissue, resulting from damage to the lymphatic system. Patients with lymphedema experience painful swelling and limitation of function of the limbs or other areas.

Complex decongestive therapy (CDT) is the multi-modal treatment for lymphedema carried out by a skilled therapist. However, in order to optimally manage the condition, some components of CDT need to be carried out by the patient on a daily basis. Self-care plays an important role for patients with lymphedema, and may include daily self-massage, skin care, compression therapy, and exercise. However, for some individuals with lymphedema, performing daily self-care poses a challenge.

Dr. Helene Lindquist, RPT, PhD, and Tommy Nyberg, MSc, and their research group at Karolinska Institute, Stockholm, performed a study to identify characteristics of women who needed extra support to self-manage their lymphedema. The study included data on 88 Swedish women, average age 62 years--most with arm lymphedema after breast cancer treatment.

Nearly 60 percent of women in the study performed their self-care program almost every day--even though about half of the patients felt that self-care did not help much. Only about 20 percent of women who worked performed daily self-care at work.

A wide range of demographic, clinical, psychological, and physical characteristics were significantly related to self-care practice. Factors associated with lower rates of daily self-care included low scores for well-being, body image, and self-esteem; ethnicity other than Swedish; depressed or anxious mood; and poor sleep quality.

"Our results emphasize the importance of focusing more on vulnerable individuals when it comes to instructions about self-care and to encourage women to perform continuous self-care," the researchers write. They believe their findings support a "stepped-care" approach to working with women with lymphedema: basic help for all women, with stepwise progressive interventions for those in need of additional support. The special issue includes a narrative by actress Kathy Bates--a breast cancer survivor with lymphedema--providing a patient's perspective on the frustrations and arduous nature of the ongoing self-care needs.

Dr. Stout notes that the special issue appears two decades after a seminal report by the American Cancer Society on lymphedema management. Since then, management of lymphedema has become "far more mainstream," with ongoing research, clinical practice guidelines, and improved access to specialist care. Other topics in the special issue include patient assessment, considerations for advanced training for physical therapy professionals in lymphedema care, and new imaging approaches.

Other papers report on sophisticated technologies like low-level laser therapy. These advances open the possibility of developing wearable sensors and cloud-based apps to provide patients with daily feedback on their condition and individualized updates for support and prevention. Dr. Stout concludes, "The future is bright, the future is smart, and we must continue to seize on opportunities to advance novel approaches to lymphedema management."
Click here to read "Self-care in Female Cancer Survivors With Secondary Lymphedema: Characteristics of Women Needing Support to Perform Self-care."

DOI: 10.1097/01.REO.0000000000000106

About Rehabilitation Oncology

Rehabilitation Oncology is the official quarterly publication of the Oncology Section of the American Physical Therapy Association. The journal is the primary peer-reviewed, indexed resource for advancing oncologic physical therapy practice and cancer rehabilitation through the dissemination of definitive evidence, translation of clinically relevant knowledge, and integration of theory into education, practice, and research.

About the Oncology Section

The Oncology Section of APTA advances physical therapist practice to maximize the lifelong health, well-being and function of persons affected by cancer and HIV. The association consists of professional Physical Therapists managing the musculoskeletal, neuromuscular, integumentary and cardiopulmonary rehabilitative needs of patients resulting from the treatment of active cancer disease. This encompasses acute secondary sequela of cancer treatments such as surgery, radiation therapy, and chemotherapy; long-term secondary sequela of said treatments and palliative care.

About Wolters Kluwer

Wolters Kluwer N.V. (AEX: WKL) is a global leader in information services and solutions for professionals in the health, tax and accounting, risk and compliance, finance and legal sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with specialized technology and services.

Wolters Kluwer reported 2016 annual revenues of €4.3 billion. The company, headquartered in Alphen aan den Rijn, the Netherlands, serves customers in over 180 countries, maintains operations in over 40 countries and employs 19,000 people worldwide.

Wolters Kluwer Health is a leading global provider of information and point of care solutions for the healthcare industry. For more information about our products and the organization, visit, follow @WKHealth or @Wolters_Kluwer on Twitter, like us on Facebook, follow us on LinkedIn, or follow WoltersKluwerComms on YouTube.

For more information about Wolters Kluwer's solutions and organization, visit, follow us on Twitter, Facebook, LinkedIn, and YouTube.

Wolters Kluwer Health

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to